What are you looking for? Write the name, title or any keyword related to what you are looking for and select which content category it belongs to. Search Fulltext search Activities Professionals Research groups News - Any - Year 2024 Data d'inici Mon, 12 Feb 2024 - 12:00 Data de tancament Mon, 26 Feb 2024 - 12:00 Grup de recerca Childhood Cancer and Blood Disorders Descripció Communication and Dissemination Manager_20240056 Codi 2024-56 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0056//2024_0056_001.pdf Reclutant Inactiu Year 2024 Data d'inici Mon, 12 Feb 2024 - 12:00 Data de tancament Mon, 26 Feb 2024 - 12:00 Grup de recerca Neurovascular Diseases Descripció Study Coordinator - Neurovascular diseases group_20240057 Codi 2024-57 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0057//2024_0057_001.pdf Reclutant Inactiu Estudio de fase 2 de la infusión de células T autólogas, diferenciadas y de sangre periférica expandidas y transducidas con un lentivirus para expresar un receptor de antígeno quimérico con especificidad anti-CD19 (A3B1) junto con regiones coestimuladoras 4-1BB y CD3z (ARI- 0001 células) en niños y adolescentes (de 0 a 18 años) con leucemia linfoblástica aguda CD19+ resistente o refractaria al tratamiento Contact Protocol code: CART19-BE-03Ped EudraCT code: 2022-001101-52 Pathology: Tumors Principal investigator: Díaz de Heredia Rubio, Maria Cristina Research group: Childhood Cancer and Blood Disorders Service: Oncohematologia Pediàtrica Phase: Fase II Recruiting: Open Status: Iniciat Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Estudio de fase 2a, aleatorizado, doble ciego y controlado con placebo para evaluar la seguridad y la tolerabilidad, la farmacocinética, la farmacodinamia y la eficacia preliminar del setanaxib, un inhibidor de NOX1/4, en pacientes con síndrome de Alport Contact Protocol code: GSN000500 EudraCT code: No aplica Pathology: Símptomes, signes i troballes anormals clíniques i de laboratori, no classificades enlloc més Principal investigator: Agraz Pamplona, Irene Research group: Nefrologia i trasplantament renal Service: Nefrologia Phase: Phase II Recruiting: Open Status: Tancat Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. A phase 3, randomized, double-blind, placebo-controlled, parallel-arm study to evaluate the efficacy and safety of RZ358 in patients with congenital hyperinsulinism. Contact Protocol code: RZ358-301 EudraCT code: _ Pathology: Malalties endocrines, nutricionals i metabòliques Principal investigator: Clemente Leon, Maria Research group: Creixement i desenvolupament Service: Pediatria General i Especialitats Phase: Fase III Recruiting: Open Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Estudio Fase 3, multicéntrico, aleatorizado, doble ciego, controlado con placebo para determinar la eficacia y seguridad de BIIB122/DNL151 en participantes con Enfermedad de Parkinson y variantes patógenas de LRRK2 Contact Protocol code: 283PD302 EudraCT code: 2022-000747-77 Principal investigator: Hernández Vara, Jorge Research group: Malalties neurodegeneratives Service: Neurologia Phase: Phase III Recruiting: Closed Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. ESTUDIO MULTICENTRO DE CONTINUACIÓN EN DOS PARTES, ALEATORIZADO, CONTROLADO CON PLACEBO, DOBLE CIEGO PARA INVESTIGAR LA SEGURIDAD, TOLERABILIDAD, FARMACOCINÉTICA, FARMACODINÁMICA Y EFICACIA DE RO7204239 EN COMBINACIÓN CON RISDIPLAM (RO7034067) EN PACIENTES CON ATROFIA MUSCULAR ESPINAL Contact Protocol code: BN42644 EudraCT code: 2021-003417-19 Pathology: Malalties del sistema nerviós Principal investigator: Gómez Andrés, David Research group: Teràpies i Innovació en Neuropediatria i altres malalties rares pediàtriques Service: General Pediatrics and Specialties Phase: Phase III Recruiting: Closed Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. ESTUDIO DE FASE III, MULTICÉNTRICO, ALEATORIZADO, CON DOBLE ENMASCARAMIENTO, CONTROLADO CON PLACEBO PARA EVALUAR LA EFICACIA, SEGURIDAD, FARMACOCINÉTICA Y FARMACODINAMIA DE SATRALIZUMAB EN PACIENTES CON ORBITOPATÍA TIROIDEA DE MODERADA A SEVERA Contact Protocol code: GP44729 EudraCT code: No aplica Pathology: Malalties de l’ull i dels seus annexos Principal investigator: Arcediano Sánchez, Miguel Ángel Research group: Oftalmologia Service: Oftalmologia Phase: Phase III Recruiting: Open Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. A 52-week randomized,double-blind, placebocontrolled, multi-center Phase 2b study with a 52-week blinded extension assessing safety and efficacy of frexalimab, a CD40L antagonist monoclonal antibody, for preservation of pancreatic ß-cell function in adults and adolescents with newly diagnosed type 1 diabetes on insulin therapy Contact Protocol code: DRI17476 EudraCT code: No aplica Pathology: Endocrine, nutritional and metabolic diseases Principal investigator: Hernández Pascual, Cristina Research group: Diabetis i metabolisme Service: Endocrinologia Phase: Phase II Recruiting: Open Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Estudio de fase III, aleatorizado, doble ciego, controlado con placebo y motivado por los acontecimientos para demostrar la eficacia y seguridad de milvexian, un inhibidor oral del factor XIa, después de padecer un síndrome coronario agudo reciente Contact Protocol code: 70033093ACS3003 EudraCT code: _ Pathology: Malalties del sistema circulatori Principal investigator: Barrabés Riu, José Antonio Research group: Malalties cardiovasculars Service: Cardiologia Phase: Phase III Recruiting: Open Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. A phase 3 multicenter, randomized, placebo-controlled, double-blind study to evaluate the efficacy and safety of eneboparatide (AZP-3601), a parathyroid hormone receptor agonist, in patients with chronic hypoparathyroidism (CALYPSO) Contact Protocol code: AZP-3601-CLI-002 EudraCT code: _ Pathology: Symptoms, signs, and abnormal clinical and laboratory findings, not elsewhere classified Principal investigator: Rojano Toimil, Alba Research group: Diabetes and Metabolism Service: Endocrinology Phase: Phase III Recruiting: Open Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Year 2024 Títol Complet Servicio de un profesional en psicología para hacer avaluaciones neuropsicológicas y almacenamiento de datos, a cargo del proyecto PI22/01082 de la Unidad de Investigación en Neurotraumatología y Neurocirugía (UNINN), de la Fundació Hospital Universitari Vall Hebron - Institut de Recerca (VHIR) Expedient AVALUACIÓN NEUROPSICOLÓGICAS (PI22/01082) Codi 24966227 Data publicació Wed, 31 Jan 2024 - 12:00 Documentos (enllaços) ANUNCIO DE LICITACIÓN PLIEGO DE CLÁUSULAS ADMINISTRATIVAS PARTICULARES ANEXO 1.PCAP PLIEGO DE CLÁUSULAS TÉCNICAS PRINCIPALES PUNTOS SOBRE DIGITAL DEUC DEUC FORMATO XML INSTRUCCIONES PARA RELLENAR EL DEUC ACUERDO DE NECESIDAD CERTIFICADO DE EXISTENCIA DE CRÉDITO RESOLUCIÓN DE APROBACIÓN DEL EXPEDIENTE RESOLUCIÓN DESIGNACIÓN MESA DE CONTRATACIÓN REQUERIMIENTO REQUERIMIENTO SOLVENCIA ECONÓMICA ACUERDO DE ADJUDICACIÓN Year 2024 Títol Complet Contractació del subministrament i instal·lació de tres cambres frigorífiques del nou edifici de la Fundació Hospital Universitari Vall d’Hebron - Institut de Recerca (VHIR) Expedient CAMBRES FRIGORIFIQUES EDIFICI VHIR Codi 24966297 Data publicació Fri, 2 Feb 2024 - 12:00 Documentos (enllaços) ANUNCI DE LICITACIÓ PLEC DE CLÀUSULES ADMINISTRATIVES PARTICULARS ANNEX 1 PCAP PLEC DE PRESCRIPCIONS TÈCNIQUES ANNEX 1 PPT ANNEX 2 PPT PRINCIPALS PUNTS SOBRE DIGITAL DEUC DEUC FORMAT XML INSTRUCCIONS PER EMPLENAR EL DEUC ACORD DE NECESSITAT CERTIFICAT D'EXISTÈNCIA DE CRÈDIT RESOLUCIÓ APROVACIÓ DE L'EXPEDIENT RESOLUCIÓ DESIGNACIÓ MESA DE CONTRACTACIÓ INFORME DE VALORACIÓ TÈCNICA Year 2024 Títol Complet Acord Marc per a l'homologació de tres proveïdors per a dur a terme els serveis d'assessorament en Dret Administratiu, destinat a la Fundació Hospital Universitari Vall Hebron - Institut de Recerca (VHIR). Expedient ASSES. DRET ADMINISTRATIU Codi 24966014 Data publicació Tue, 30 Jan 2024 - 12:00 Documentos (enllaços) ANNEX 1 -PCAP (word) PRINCIPALS PUNTS SOBRE DIGITAL DEUC DEUC FORMAT XML INSTRUCCIONS PER EMPLENAR EL DEUC ACORD DE NECESSITAT CERTIFICAT D'EXISTÈNCIA DE CRÈDIT ANUNCI DE LICITACIÓ PLEC DE CLÀUSULES ADMINISTRATIVES PARTICULARS PLEC DE PRESCRIPCIONS TÈCNIQUES RESOLUCIÓ D'APROVACIÓ DE L'EXPEDIENT RESOLUCIÓ DESIGNACIÓ DE LA MESA DE CONTRACTACIÓ ACORD ADJUDICACIÓ ACORD ADJUDICACIÓ ACORD ADJUDICACIÓ Professionals Macias Chimborazo, Valeria Professionals Guerrero Flores, Javier Year 2024 Data d'inici Fri, 9 Feb 2024 - 12:00 Data de tancament Sun, 3 Mar 2024 - 12:00 Grup de recerca Childhood Cancer and Blood Disorders Descripció Experienced Project Manager – European Rare Blood disorders Registries_20240055 Codi 2024-55 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0055//2024_0055_001.pdf Reclutant Inactiu Year 2024 Data d'inici Tue, 6 Feb 2024 - 12:00 Data de tancament Tue, 20 Feb 2024 - 12:00 Grup de recerca Growth and Development Descripció Clinical Researcher in Pediatric Endocrinology_20240052 Codi 2024-52 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0052//2024_0052_001.pdf Reclutant Inactiu Year 2024 Data d'inici Tue, 6 Feb 2024 - 12:00 Data de tancament Tue, 20 Feb 2024 - 12:00 Grup de recerca Hepato-bilio-pancreatic surgery (HBP) and liver transplantation Descripció Researcher Technician-Hepato-bilio-pancreatic surgery (HBP) and liver transplantation_20240053 Codi 2024-53 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0053//2024_0053_001.pdf Reclutant Inactiu Year 2024 Data d'inici Tue, 6 Feb 2024 - 12:00 Data de tancament Fri, 23 Feb 2024 - 12:00 Grup de recerca Childhood Cancer and Blood Disorders Descripció Biostatistician_20240054 Codi 2024-54 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0054//2024_0054_001.pdf Reclutant Inactiu Pagination First page « Previous page ‹ … Page 1449 Page 1450 Current page 1451 Page 1452 Page 1453 … Next page › Last page »
Year 2024 Data d'inici Mon, 12 Feb 2024 - 12:00 Data de tancament Mon, 26 Feb 2024 - 12:00 Grup de recerca Childhood Cancer and Blood Disorders Descripció Communication and Dissemination Manager_20240056 Codi 2024-56 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0056//2024_0056_001.pdf Reclutant Inactiu
Year 2024 Data d'inici Mon, 12 Feb 2024 - 12:00 Data de tancament Mon, 26 Feb 2024 - 12:00 Grup de recerca Neurovascular Diseases Descripció Study Coordinator - Neurovascular diseases group_20240057 Codi 2024-57 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0057//2024_0057_001.pdf Reclutant Inactiu
Year 2024 Títol Complet Servicio de un profesional en psicología para hacer avaluaciones neuropsicológicas y almacenamiento de datos, a cargo del proyecto PI22/01082 de la Unidad de Investigación en Neurotraumatología y Neurocirugía (UNINN), de la Fundació Hospital Universitari Vall Hebron - Institut de Recerca (VHIR) Expedient AVALUACIÓN NEUROPSICOLÓGICAS (PI22/01082) Codi 24966227 Data publicació Wed, 31 Jan 2024 - 12:00 Documentos (enllaços) ANUNCIO DE LICITACIÓN PLIEGO DE CLÁUSULAS ADMINISTRATIVAS PARTICULARES ANEXO 1.PCAP PLIEGO DE CLÁUSULAS TÉCNICAS PRINCIPALES PUNTOS SOBRE DIGITAL DEUC DEUC FORMATO XML INSTRUCCIONES PARA RELLENAR EL DEUC ACUERDO DE NECESIDAD CERTIFICADO DE EXISTENCIA DE CRÉDITO RESOLUCIÓN DE APROBACIÓN DEL EXPEDIENTE RESOLUCIÓN DESIGNACIÓN MESA DE CONTRATACIÓN REQUERIMIENTO REQUERIMIENTO SOLVENCIA ECONÓMICA ACUERDO DE ADJUDICACIÓN
Year 2024 Títol Complet Contractació del subministrament i instal·lació de tres cambres frigorífiques del nou edifici de la Fundació Hospital Universitari Vall d’Hebron - Institut de Recerca (VHIR) Expedient CAMBRES FRIGORIFIQUES EDIFICI VHIR Codi 24966297 Data publicació Fri, 2 Feb 2024 - 12:00 Documentos (enllaços) ANUNCI DE LICITACIÓ PLEC DE CLÀUSULES ADMINISTRATIVES PARTICULARS ANNEX 1 PCAP PLEC DE PRESCRIPCIONS TÈCNIQUES ANNEX 1 PPT ANNEX 2 PPT PRINCIPALS PUNTS SOBRE DIGITAL DEUC DEUC FORMAT XML INSTRUCCIONS PER EMPLENAR EL DEUC ACORD DE NECESSITAT CERTIFICAT D'EXISTÈNCIA DE CRÈDIT RESOLUCIÓ APROVACIÓ DE L'EXPEDIENT RESOLUCIÓ DESIGNACIÓ MESA DE CONTRACTACIÓ INFORME DE VALORACIÓ TÈCNICA
Year 2024 Títol Complet Acord Marc per a l'homologació de tres proveïdors per a dur a terme els serveis d'assessorament en Dret Administratiu, destinat a la Fundació Hospital Universitari Vall Hebron - Institut de Recerca (VHIR). Expedient ASSES. DRET ADMINISTRATIU Codi 24966014 Data publicació Tue, 30 Jan 2024 - 12:00 Documentos (enllaços) ANNEX 1 -PCAP (word) PRINCIPALS PUNTS SOBRE DIGITAL DEUC DEUC FORMAT XML INSTRUCCIONS PER EMPLENAR EL DEUC ACORD DE NECESSITAT CERTIFICAT D'EXISTÈNCIA DE CRÈDIT ANUNCI DE LICITACIÓ PLEC DE CLÀUSULES ADMINISTRATIVES PARTICULARS PLEC DE PRESCRIPCIONS TÈCNIQUES RESOLUCIÓ D'APROVACIÓ DE L'EXPEDIENT RESOLUCIÓ DESIGNACIÓ DE LA MESA DE CONTRACTACIÓ ACORD ADJUDICACIÓ ACORD ADJUDICACIÓ ACORD ADJUDICACIÓ
Year 2024 Data d'inici Fri, 9 Feb 2024 - 12:00 Data de tancament Sun, 3 Mar 2024 - 12:00 Grup de recerca Childhood Cancer and Blood Disorders Descripció Experienced Project Manager – European Rare Blood disorders Registries_20240055 Codi 2024-55 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0055//2024_0055_001.pdf Reclutant Inactiu
Year 2024 Data d'inici Tue, 6 Feb 2024 - 12:00 Data de tancament Tue, 20 Feb 2024 - 12:00 Grup de recerca Growth and Development Descripció Clinical Researcher in Pediatric Endocrinology_20240052 Codi 2024-52 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0052//2024_0052_001.pdf Reclutant Inactiu
Year 2024 Data d'inici Tue, 6 Feb 2024 - 12:00 Data de tancament Tue, 20 Feb 2024 - 12:00 Grup de recerca Hepato-bilio-pancreatic surgery (HBP) and liver transplantation Descripció Researcher Technician-Hepato-bilio-pancreatic surgery (HBP) and liver transplantation_20240053 Codi 2024-53 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0053//2024_0053_001.pdf Reclutant Inactiu
Year 2024 Data d'inici Tue, 6 Feb 2024 - 12:00 Data de tancament Fri, 23 Feb 2024 - 12:00 Grup de recerca Childhood Cancer and Blood Disorders Descripció Biostatistician_20240054 Codi 2024-54 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0054//2024_0054_001.pdf Reclutant Inactiu
